Bayer cancels diabetes device unit sale: paper
FRANKFURT (Reuters) - Bayer AG has called off the sale of its blood glucose meters business for now, Financial Times Deutschland reported, citing industry and financial sources.
According to the paper, Germany's largest drugmaker could not find a buyer who was willing to pay the asking price.
The unit has annual sales of about 1 billion euros ($1.3 billion), which would value it at 1-2 billion euros, based on current multiples, the paper said.
Sources told Reuters in May Bayer was considering the sale of the unit, because it offers few synergies with its other healthcare activities.
($1 = 0.7716 euros)
(Reporting by Harro ten Wolde)
Robert Blendon of the Harvard School of Public Health says the Affordable Care Act's unpopularity in 12 key states will keep it a central issue in the 2014 elections. Video